MENU
TSHA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Taysha Gene Therapies (TSHA) Ownership - Who owns Taysha Gene Therapies?
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease... Show more
Profile
Industry
N/A
Address
3000 Pegasus Park Drive
Phone
+1 214 612-0000
Employees
52
Web
https://www.tayshagtx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
365M
P/E Ratio
2.70
Total Cash
139.04M
Projected Growth
N/A
Total Debt
63.18M
Revenue
8.33M
Risk (Beta)
0.87
Dividend Yield
N/A
Total Cash/Share
0.68
Total Debt/Equity
N/A
Revenue/Share
0.03 USD as % of share price
Fundamentals
TSHA
Capitalization
365M
P/E Ratio
2.70
Risk (Beta)
0.87
Dividend Yield
N/A
Total Cash
139M
Total Cash/Share
0.68
Total Debt
63.2M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.03%
Revenue
8.33M
ROE
N/A
Book Value
71.5M
P/B Ratio
5.10
Cash Flow
N/A
Earnings
-0.36
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2K
Current Ratio
5.42
Current Revenue Per Employee
27698.63
Dividends Per Share - Security
N/A
EBITDA
-87.95M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-53.62
Shares Held By Institutions
368M
Shares Outstanding - Current
205M
Total Liabilities
88.8M
Total Volume MTD
N/A
Value
N/A
Gain YTD
5.202
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
3000 Pegasus Park Drive
Phone
+1 214 612-0000
Employees
52
Web
https://www.tayshagtx.com